1. Association for Molecular Pathology v. Myriad Genetics, Inc. 133 S. Ct. 2107 (2013).
2. Burk, D.L. J. Law Biosci. 2, 606–626 (2015).
3. USPTO. 2014 interim guidance on patent subject matter eligibility. Fed. Regist. 79, 74618–74633 (2014).
4. USPTO. July 2015 update: subject matter eligibility (USPTO, Alexandria, Virginia)
https://www.uspto.gov/sites/default/files/documents/ieg-july-2015-update.pdf
(2015).
5. Bahr, R. W. Formulating a subject matter eligibility rejection and evaluating the applicant's response to a subject matter eligibility rejection (USPTO, Alexandria, Virginia)
https://www.uspto.gov/sites/default/files/documents/ieg-may-2016-memo.pdf
(2016).